Chemophototherapeutic Ablation of <scp>Doxorubicin‐Resistant</scp> Human Ovarian Tumor Cells <sup>†</sup>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemophototherapeutic Ablation of Doxorubicin‐Resistant Human Ovarian Tumor Cells ^†

Published:2022-08-02 Issue:2 Volume:99 Page:844-849
ISSN:0031-8655
Container-title:Photochemistry and Photobiology
language:en
Short-container-title:Photochem & Photobiology

Author:

Ghosh Sanjana¹,Chitgupi Upendra¹²,Sunar Ulas³,Lovell Jonathan F.¹^ORCID

Affiliation:

1. Department of Biomedical Engineering University at Buffalo, State University of New York Buffalo NY

2. Nektar Therapeutics, Formulations Group San Francisco CA

3. Department of Biomedical, Industrial & Human Factors Engineering Wright State University Dayton OH

Funder

National Institutes of Health

Publisher

Wiley

Subject

Physical and Theoretical Chemistry,General Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/php.13677

Reference26 articles.

1. Diagnosis and Treatment of Ovarian Cancer

2. Improved early detection of ovarian cancer using longitudinal multimarker models

3. Systemic Therapy for Ovarian Cancer: Current Status and New Treatments

4. Adriamycin

5. Doxil® — The first FDA-approved nano-drug: Lessons learned

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano‐Titanium Oxide‐Coated Carbon Nanotubes for Photothermal Therapy in the Treatment of Colorectal Cancer;Advanced Healthcare Materials;2024-06-22

2. Metabolomics profiling and chemoresistance mechanisms in ovarian cancer cell lines: Implications for targeting glutathione pathway;Life Sciences;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP